Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice
- PMID: 4588620
- DOI: 10.1126/science.183.4124.534
Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice
Abstract
Athymic-nude (nu/nu) mice and normal (nu/+) mice showed no differences in either latent period or incidence of local sarcomas or lung adenomas within 120 days after administration of 3-methylcholanthrene at birth. However, nu/nu mice were incapable of rejecting allogeneic skin grafts for the duration of the experiment. These results argue against an active role of thymus-dependent immunity as a surveillance mechanism preventing tumor development.
Similar articles
-
CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.Clin Exp Immunol. 2000 Aug;121(2):210-5. doi: 10.1046/j.1365-2249.2000.01292.x. Clin Exp Immunol. 2000. PMID: 10931133 Free PMC article.
-
Chemical carcinogenesis in mice inhibited by interferon.Nat New Biol. 1972 Sep 6;239(88):31-2. doi: 10.1038/newbio239031a0. Nat New Biol. 1972. PMID: 4342748 No abstract available.
-
Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.Cancer Res. 1974 Jan;34(1):61-71. Cancer Res. 1974. PMID: 4809463 No abstract available.
-
The nude mouse: a model of deficient T-cell function.Methods Achiev Exp Pathol. 1975;7:149-66. Methods Achiev Exp Pathol. 1975. PMID: 1105061 Review.
-
Tumor immunology with particular reference to malignant melanoma.Int J Dermatol. 1975 Jan-Feb;14(1):3-11. doi: 10.1111/j.1365-4362.1975.tb00071.x. Int J Dermatol. 1975. PMID: 1092622 Review. No abstract available.
Cited by
-
The concept of immune surveillance against tumors. The first theories.Oncotarget. 2017 Jan 24;8(4):7175-7180. doi: 10.18632/oncotarget.12739. Oncotarget. 2017. PMID: 27764780 Free PMC article. Review.
-
Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.Neuro Oncol. 2012 May;14(5):584-95. doi: 10.1093/neuonc/nos014. Epub 2012 Mar 9. Neuro Oncol. 2012. PMID: 22406925 Free PMC article.
-
The role of the immune response in oncogenesis.In Vitro. 1975 May-Jun;11(3):166-72. doi: 10.1007/BF02615424. In Vitro. 1975. PMID: 1165104 No abstract available.
-
Cancer immunoediting from immune surveillance to immune escape.Immunology. 2007 May;121(1):1-14. doi: 10.1111/j.1365-2567.2007.02587.x. Epub 2007 Mar 26. Immunology. 2007. PMID: 17386080 Free PMC article. Review.
-
Revisiting cancer immunoediting by understanding cancer immune complexity.J Pathol. 2011 May;224(1):5-9. doi: 10.1002/path.2865. J Pathol. 2011. PMID: 21480229 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials